CLINICAL_TRIALS
ClinicalTrials.gov record update
A Randomized, Double-Masked, Placebo-Controlled, Dose- Finding, Non-Inferiority Study of X-82 Plus Prn Intravitreal (Ivt) Anti-VEGF Compared to Prn Ivt Anti-VEGF Monotherapy in Neovascular AMD
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02348359
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:48.458373+00:00
- Published At
- 2018-06-27T00:00:00+00:00
- Record Updated At
- 2022-02-11
- Results Posted At
- 2018-06-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Age-Related Macular Degeneration (AMD)", "Macular Degeneration", "Exudative Age-related Macular Degeneration", "AMD", "Macular Degeneration, Age-related, 10", "Eye Diseases", "Retinal Degeneration", "Retinal Diseases"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-02-11"- protocolSection.identificationModule.nctId
"NCT02348359"- protocolSection.identificationModule.officialTitle
"A Randomized, Double-Masked, Placebo-Controlled, Dose- Finding, Non-Inferiority Study of X-82 Plus Prn Intravitreal (Ivt) Anti-VEGF Compared to Prn Ivt Anti-VEGF Monotherapy in Neovascular AMD"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-06-27"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.